同仁堂参苓白术散获加拿大产品许可证，海外市场拓展迈出关键一步

中访网数据12-09

中访网数据北京同仁堂股份有限公司于12月9日发布公告，其分支机构北京同仁堂股份有限公司同仁堂制药厂生产的参苓白术散已获得加拿大卫生部颁发的《产品许可证(三类)》。该许可证为产品上市许可，标志着该传统中药产品在加拿大市场获得了官方注册。根据公告，该产品在加拿大的适应症为基于传统中医药理论，用于缓解脾胃虚弱、食少便溏、气短咳嗽及肢倦乏力等症状。同仁堂制药厂就该产品的研发累计投入约229万元。公司...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2590344752?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-09 09:26","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2590344752","market":"hk","top_or_hot":-1,"title":"同仁堂参苓白术散获加拿大产品许可证，海外市场拓展迈出关键一步","media":"中访网数据","content":"<div>\n<p>中访网数据  北京同仁堂股份有限公司于12月9日发布公告，其分支机构北京同仁堂股份有限公司同仁堂制药厂生产的参苓白术散已获得加拿大卫生部颁发的《产品许可证(三类)》。该许可证为产品上市许可，标志着该传统中药产品在加拿大市场获得了官方注册。根据公告，该产品在加拿大的适应症为基于传统中医药理论，用于缓解脾胃虚弱、食少便溏、气短咳嗽及肢倦乏力等症状。同仁堂制药厂就该产品的研发累计投入约229万元。公司...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209093237a43c76d5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>同仁堂参苓白术散获加拿大产品许可证，海外市场拓展迈出关键一步</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n同仁堂参苓白术散获加拿大产品许可证，海外市场拓展迈出关键一步\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-09 09:26 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209093237a43c76d5&s=b><strong>中访网数据</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中访网数据  北京同仁堂股份有限公司于12月9日发布公告，其分支机构北京同仁堂股份有限公司同仁堂制药厂生产的参苓白术散已获得加拿大卫生部颁发的《产品许可证(三类)》。该许可证为产品上市许可，标志着该传统中药产品在加拿大市场获得了官方注册。根据公告，该产品在加拿大的适应症为基于传统中医药理论，用于缓解脾胃虚弱、食少便溏、气短咳嗽及肢倦乏力等症状。同仁堂制药厂就该产品的研发累计投入约229万元。公司...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209093237a43c76d5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209093237a43c76d5&s=b","article_id":"2590344752","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209093237a43c76d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2590344752","pubTimestamp":1765243610,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"中访网数据  北京同仁堂股份有限公司于12月9日发布公告，其分支机构北京同仁堂股份有限公司同仁堂制药厂生产的参苓白术散已获得加拿大卫生部颁发的《产品许可证(三类)》。该许可证为产品上市许可，标志着该传统中药产品在加拿大市场获得了官方注册。此次获批是同仁堂推动中药产品国际化、拓展北美市场的重要进展。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","03613":"同仁堂国药","BK1606":"中医药概念"},"translate_title":"Tongrentang Shenling Baizhu Powder obtained a Canadian product license, taking a key step in overseas market expansion","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":0.9},"content_text":"中访网数据  北京同仁堂股份有限公司于12月9日发布公告，其分支机构北京同仁堂股份有限公司同仁堂制药厂生产的参苓白术散已获得加拿大卫生部颁发的《产品许可证(三类)》。该许可证为产品上市许可，标志着该传统中药产品在加拿大市场获得了官方注册。根据公告，该产品在加拿大的适应症为基于传统中医药理论，用于缓解脾胃虚弱、食少便溏、气短咳嗽及肢倦乏力等症状。同仁堂制药厂就该产品的研发累计投入约229万元。公司提示，该产品若要在加拿大上市销售，后续仍需完成包括生产场地质量体系认证在内的其他行政审批，存在不确定性。公司同时表示，此次获批对公司近期经营业绩不会产生重大影响，且产品在境外销售还面临政策环境、市场推广、竞争等多重风险。此次获批是同仁堂推动中药产品国际化、拓展北美市场的重要进展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590344752","isCrawlerRequest":true}